PK ̖N K Contrast of controllable - uncontrollable baseline trials/124201.L.func.giim]Ǒ ecbFPrX417(RaVҿ̮̾B(ɲˋ{O~|W?(?O=}/~l}~~O~OG_W_~_7o?9_?___/Ջ|'W/^/~˟~x^W_ū'ŗ//O>|~/ſ~?^/W|W??z_Gv_~?j~[u_^|ߟ}O_m_2WK>~_|uW_~ڗO?ѧ˧?GodGQbYFYeǓܽn-l_pŌ_yzuJtXrIY.59֪V|*糽{oң[m{lxqˍ/ŖkXc כvغOr߀ݰwt%eװvu%omԷ{2 0tJڥ͝%\qz}^JJDz<%=ʽUJ{gj'OǎZݳ=+nL-a.qƅ6VOwNca {g+0Pfmyg$_\Ɗxh5>5`4afMVgSV
r|AY:=
ܼH|]$s(lWr
.ٰX%^3%19[Gz)Ú,L]lss}6X[^6{\߿axehƌFXDW5Zm; |l=,eVq>\qxayZ}ͣw}˅rfXBdB6mc
5zYϰ08{m"ac8@aw8.t*,Pߊ*g\C0V*:'.68RN